Alaunos Therapeutics (TCRT) EBIT Margin Growth (1y) (2012 - 2025)
Alaunos Therapeutics (TCRT) EBIT Margin Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-1.14 Mn |
| Mar 31, 2025 |
11.96 Mn |
| Dec 31, 2024 |
77.60 Mn |
| Jun 30, 2024 |
17.04 Mn |
| Dec 31, 2023 |
-71.74 Mn |
| Dec 31, 2022 |
47.51 Mn |
| Sep 30, 2022 |
531,812.00 |
| Mar 31, 2018 |
-1.02 Mn |
| Dec 31, 2017 |
-14,559.00 |
| Sep 30, 2017 |
-13,542.00 |
| Jun 30, 2017 |
691,886.00 |
| Mar 31, 2017 |
-26,297.00 |
| Dec 31, 2016 |
-20,163.00 |
| Sep 30, 2016 |
28,898.00 |
| Jun 30, 2016 |
-250,399.00 |
| Mar 31, 2016 |
2.81 Mn |
| Dec 31, 2015 |
262,236.00 |
| Sep 30, 2015 |
91,461.00 |
| Jun 30, 2015 |
35,872.00 |
| Mar 31, 2015 |
-2.39 Mn |
